Welcome to our dedicated page for Chase Packaging SEC filings (Ticker: WHLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Chase Packaging's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Chase Packaging's regulatory disclosures and financial reporting.
Chase Packaging Corporation is changing the terms of its outstanding common stock purchase warrants. The company has extended the warrants’ expiration date from March 7, 2026 to March 7, 2029, giving holders three additional years to exercise their rights.
These warrants allow holders to buy an aggregate of 6,909,000 shares of Chase Packaging common stock. The company is issuing replacement warrant certificates, and the form of the new warrant agreement and certificate is included as an exhibit to this report.
Chase Packaging Corporation reported a small operating footprint with no revenue and a continued focus on maintaining public company status while seeking a merger or acquisition. For Q3 2025, the company posted a net loss of $17,569, compared with $18,199 a year ago. For the nine months ended September 30, 2025, the net loss was $61,962 versus $76,831 in the prior year period, reflecting lower audit and accounting fees.
Cash and cash equivalents were $240,748 at September 30, 2025, invested in money market funds and U.S. Treasury/government securities. Total assets matched cash, current liabilities were $8,473, and stockholders’ equity was $232,275. Management states available cash is sufficient for at least the next twelve months and for costs of pursuing an acquisition.
There were 61,882,172 common shares outstanding as of October 28, 2025. Warrants to purchase 6,909,000 shares at an exercise price of $0.15 remain outstanding and expire on March 7, 2026; intrinsic value at quarter-end was $0. The company recorded no stock-based compensation and reported no legal proceedings.